Dynamic Technology Lab Private LTD Fate Therapeutics Inc Transaction History

Dynamic Technology Lab Private LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$21.04 - $36.06 $438,052 - $750,769	20,820 New	20,820 $467,000
Q3 2022 Nov 14, 2022	BUY	$21.04 - $36.06 $438,052 - $750,769	20,820 New	20,820 $467,000
Q4 2021 Feb 14, 2022	SELL	$47.84 - $64.34 $498,014 - $669,779	-10,410 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$59.27 - $95.73 $250,119 - $403,980	4,220 Added 68.17%	10,410 $617,000
Q2 2021 Aug 13, 2021	SELL	$67.25 - $92.52 $116,813 - $160,707	-1,737 Reduced 21.91%	6,190 $537,000
Q1 2021 May 14, 2021	BUY	$72.16 - $117.4 $572,012 - $930,629	7,927 New	7,927 $654,000
Q3 2020 Nov 13, 2020	SELL	$30.41 - $40.5 $267,547 - $356,319	-8,798 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$20.21 - $35.23 $177,807 - $309,953	8,798 New	8,798 $302,000
Q1 2020 May 13, 2020	SELL	$17.28 - $31.88 $466,992 - $861,557	-27,025 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$13.39 - $20.73 $361,864 - $560,228	27,025 New	27,025 $529,000
Q2 2019 Aug 14, 2019	SELL	$15.61 - $20.44 $161,048 - $210,879	-10,317 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$13.15 - $18.71 $135,668 - $193,031	10,317 New	10,317 $181,000

177

113M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $126M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.